Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Add-on fluvoxamine of no benefit in mild-to-moderate COVID-19

Add-on fluvoxamine of no benefit in mild-to-moderate COVID-19

07 Jul 2023

In the treatment of patients with mild-to-moderate COVID-19, adding fluvoxamine to favipiravir does not appear to prevent disease progression or improve certain outcomes, according to the results of an open-label study.

07 Jul 2023